Q2 2026 Holdings
Filed 2026-08-07 | 61 holdings | $544.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tesla Inc(TSLA) | COM | 88160R101 | $95.9M | 228,000 | 17.6% |
| Shopify Inc(SHOP) | CL A SUB VTG SHS | 82509L107 | $42.2M | 370,000 | 7.8% |
| Advanced Micro Devices Inc(AMD) | COM | 007903107 | $36.0M | 62,000 | 6.6% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $33.4M | 140,000 | 6.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $25.4M | 319,924 | 4.7% |
| Spotify Technology S A(SPOT) | SHS | L8681T102 | $25.3M | 55,000 | 4.6% |
| Palantir Technologies Inc(PLTR) | CL A | 69608A108 | $23.3M | 200,000 | 4.3% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $19.1M | 234,222 | 3.5% |
| Opendoor Technologies Inc(OPEN) | COM | 683712103 | $18.2M | 3,940,904 | 3.3% |
| Lemonade Inc(LMND) | COM | 52567D107 | $17.6M | 270,259 | 3.2% |
| Nvidia Corporation(NVDA) | COM | 67066G104 | $16.2M | 81,000 | 3.0% |
| Iren Limited(IREN) | ORDINARY SHARES | Q4982L109 | $15.6M | 340,150 | 2.9% |
| Uniqure NV(QURE) | SHS | N90064101 | $15.1M | 328,322 | 2.8% |
| Cerebras Systems Inc(CBRS) | COM CL A *A* | 15675D103 | $13.4M | 60,500 | 2.5% |
| AST Spacemobile Inc(ASTS) | COM CL A | 00217D100 | $12.9M | 145,000 | 2.4% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $11.3M | 338,800 | 2.1% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $10.5M | 399,367 | 1.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $10.5M | 48,400 | 1.9% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $10.3M | 5,520,024 | 1.9% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $9.8M | 39,944 | 1.8% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $7.7M | 210,000 | 1.4% |
| Space Exploration Techn Corp(SPCX) | CLASS A COM STK *A* | 84615Q103 | $6.8M | 40,000 | 1.3% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $5.9M | 229,857 | 1.1% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $4.7M | 9,400 | 0.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $4.3M | 75,000 | 0.8% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $4.2M | 11,170 | 0.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $3.4M | 11,372 | 0.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $3.2M | 173,516 | 0.6% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $2.8M | 30,100 | 0.5% |
| Hims & Hers Health Inc(HIMS) | COM CL A | 433000106 | $2.8M | 80,000 | 0.5% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $2.6M | 196,112 | 0.5% |
| Ambev SA(ABEV) | SPONSORED ADR | 02319V103 | $2.5M | 802,167 | 0.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $2.5M | 136,500 | 0.5% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $2.5M | 44,974 | 0.5% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $2.4M | 70,282 | 0.4% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $2.3M | 122,189 | 0.4% |
| Moderna Inc(MRNA) | COM | 60770K107 | $2.1M | 29,994 | 0.4% |
| Cartesian Therapeutics Inc(RNAC) | COM NEW | 816212302 | $1.6M | 151,675 | 0.3% |
| Magnum ICE Cream Co NV(MICC) | ORD SHS | N5505D105 | $1.5M | 98,221 | 0.3% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $1.4M | 241,010 | 0.3% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $1.4M | 198,900 | 0.2% |
| Zoetis Inc(ZTS) | CL A | 98978V103 | $1.2M | 17,322 | 0.2% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $1.2M | 90,110 | 0.2% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $1.1M | 414,311 | 0.2% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $1.0M | 35,400 | 0.2% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $835.0K | 244,146 | 0.2% |
| NOV Inc(NOV) | COM | 62955J103 | $779.6K | 42,026 | 0.1% |
| B2gold Corp(BTG) | COM | 11777Q209 | $729.6K | 195,083 | 0.1% |
| Totalenergies SE(TTE) | ACT | F92124100 | $729.5K | 10,723 | 0.1% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $722.3K | 155,000 | 0.1% |